NEW YORK STATE COMMON RETIREMENT FUND - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$242
-18.2%
44,396
+0.8%
0.00%
Q2 2023$296
-40.2%
44,063
-21.4%
0.00%
-100.0%
Q1 2023$495
-17.4%
56,086
-28.5%
0.00%0.0%
Q4 2022$599
-99.9%
78,411
-0.1%
0.00%0.0%
Q3 2022$559,000
-10.8%
78,462
+1.2%
0.00%0.0%
Q2 2022$627,000
-59.4%
77,526
-30.3%
0.00%
-50.0%
Q1 2022$1,544,000
-55.2%
111,236
-9.4%
0.00%
-33.3%
Q4 2021$3,444,000
-17.4%
122,7360.0%0.00%
-25.0%
Q3 2021$4,172,000
-16.8%
122,7360.0%0.00%
-20.0%
Q2 2021$5,015,000
-3.2%
122,736
-4.7%
0.01%
-16.7%
Q1 2021$5,183,000
-58.6%
128,744
-39.1%
0.01%
-57.1%
Q4 2020$12,506,000
+16.2%
211,506
-4.4%
0.01%
+7.7%
Q3 2020$10,762,000
-1.9%
221,306
-2.4%
0.01%
-7.1%
Q2 2020$10,973,000
+179.7%
226,806
+60.6%
0.01%
+133.3%
Q1 2020$3,923,000
+339.3%
141,206
+373.3%
0.01%
+500.0%
Q4 2019$893,000
+110.6%
29,836
+117.2%
0.00%0.0%
Q3 2019$424,000
+21100.0%
13,736
+27372.0%
0.00%
Q2 2019$2,000500.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders